Related references
Note: Only part of the references are listed.Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target
Vida Hashemi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer
Lin Li et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
The role of immune infiltrates as prognostic biomarkers in patients with breast cancer
Constantin N. Baxevanis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic
Wei Liu et al.
CANCER SCIENCE (2019)
Heat shock proteins create a signature to predict the clinical outcome in breast cancer
Marta Klimczak et al.
SCIENTIFIC REPORTS (2019)
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
Jing-Hua Pan et al.
FRONTIERS IN IMMUNOLOGY (2019)
TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
Alvaro de Mingo Pulido et al.
CANCER CELL (2018)
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
Paula Michea et al.
NATURE IMMUNOLOGY (2018)
GeneMANIA update 2018
Max Franz et al.
NUCLEIC ACIDS RESEARCH (2018)
TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor
Danilo Swann Matassa et al.
GENES (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
Si-Qi Qiu et al.
CANCER TREATMENT REVIEWS (2018)
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
Kenichi Harano et al.
PLOS ONE (2018)
Immune Landscape of Breast Cancers
Divya Nagarajan et al.
BIOMEDICINES (2018)
Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication
Samantha Burugu et al.
BREAST CANCER (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
Cinzia Solinas et al.
BREAST (2017)
The role of IL17B-IL17RB signaling pathway in breast cancer
Vahideh Alinejad et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Mechanisms of Hsp90 regulation
Chrisostomos Prodromou
BIOCHEMICAL JOURNAL (2016)
Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+Tregs : a systematic review and meta-analysis
Jiafeng Shou et al.
BMC CANCER (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94
Ephraim A. Ansa-Addo et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy
Michal Jarzab et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2016)
Relevance of tumor-infiltrating lymphocytes in breast cancer
Sathana Dushyanthen et al.
BMC MEDICINE (2015)
Clinical implications of the intrinsic molecular subtypes of breast cancer
Aleix Prat et al.
BREAST (2015)
Immune microenvironment as a factor of breast cancer progression
Anatolii Romaniuk et al.
DIAGNOSTIC PATHOLOGY (2015)
Maximizing the Therapeutic Potential of HSP90 Inhibitors
Lisa M. Butler et al.
MOLECULAR CANCER RESEARCH (2015)
Natural and therapy-induced immunosurveillance in breast cancer
Guido Kroemer et al.
NATURE MEDICINE (2015)
Systematic pan-cancer analysis of tumour purity
Dvir Aran et al.
NATURE COMMUNICATIONS (2015)
Targeting Heat-Shock Protein 90 (HSP90) as a Complementary Strategy to Immune Checkpoint Blockade for Cancer Therapy
David A. Proia et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
Brian D. Lehmann et al.
JOURNAL OF PATHOLOGY (2014)
Heat Shock Protein-90 Inhibitors Enhance Antigen Expression on Melanomas and Increase T Cell Recognition of Tumor Cells
Timothy J. Haggerty et al.
PLOS ONE (2014)
A Role for T-Lymphocytes in Human Breast Cancer and in Canine Mammary Tumors
Maria Isabel Carvalho et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Prognostic significance of FOXP3+tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration
Shuzhen Liu et al.
BREAST CANCER RESEARCH (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Xiaoqiang Tang
CANCER LETTERS (2013)
Microbial and human heat shock proteins as 'danger signals' in sarcoidosis
Anna Dubaniewicz
HUMAN IMMUNOLOGY (2013)
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Chunyan Gu-Trantien et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A Screening Assay to Identify Agents That Enhance T-Cell Recognition of Human Melanomas
Timothy J. Haggerty et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2012)
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
Catharina Medrek et al.
BMC CANCER (2012)
Molecular Pathways: Targeting Hsp90-Who Benefits and Who Does Not
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2012)
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Len Neckers et al.
CLINICAL CANCER RESEARCH (2012)
Proteomic Analyses Reveal High Expression of Decorin and Endoplasmin (HSP90B1) Are Associated with Breast Cancer Metastasis and Decreased Survival
Thomas R. Cawthorn et al.
PLOS ONE (2012)
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer
Qing Cheng et al.
BREAST CANCER RESEARCH (2012)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
X chromosomal abnormalities in basal-like human breast cancer
AL Richardson et al.
CANCER CELL (2006)
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
HJ Zhao et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Share Paper
